EPISODE · Jul 16, 2025 · 2 MIN
DMD疗法再受挫：FDA否决Capricor细胞疗法，背后有何隐情？20250713
from 生物科技 · host Rei
一款曾被寄予厚望的细胞疗法，如今却被FDA拒之门外。Capricor的Deramiocel因疗效证据不足，再次折戟于杜氏肌营养不良治疗的艰难战场。就在另一款DMD新药Sevasemten也遭遇滑铁卢、甚至已有患者因基因疗法身亡的当下，我们不禁要问：DMD药物研发，究竟卡在了哪里？
Embed this episode
NOW PLAYING
DMD疗法再受挫：FDA否决Capricor细胞疗法，背后有何隐情？20250713
0:00
2:41
1×
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.
Frequently Asked Questions
How long is this episode of 生物科技?
This episode is 2 minutes long.
When was this 生物科技 episode published?
This episode was published on July 16, 2025.
Can I download this 生物科技 episode?
Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!